Becker’s Hospital Review
Buyer Beware: DOJ Pursuing Private Equity Investors in Healthcare
December 20, 2018
As many in the healthcare industry have come to appreciate, the Civil War-era False Claims Act (“FCA”) is an exceptionally broad statute that has been the Department of Justice’s (“DOJ”) primary lever over the last twenty years in extracting billions of dollars of recoveries from healthcare providers accused of conduct ranging from clear fraud to regulatory infractions.
View the complete article on the Becker's Hospital Review website.
Contacts
Related Blogs
Capabilities
Suggested News & Insights
Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Sidley Lawyers Jaime Jones, Jennifer Saulino, and Lisa Miller to Speak at the ABA′s 2026 Qui Tam & Civil False Claims and Healthcare Fraud Institute in Washington, D.C.Wednesday, May 27, 2026 – Thursday, May 28, 2026Sidley Represents MacroGenics in the Sale of Its GMP Manufacturing OperationsMay 11, 2026DOJ’s National Fraud Enforcement Division Launches West Coast Health Care Fraud Strike ForceMay 6, 2026Sidley Matter Named “Deal of the Year” at D CEO Mergers & Acquisition Awards 2026May 5, 2026E.D. Pa. Rejects Indefinite Sealing of FCA Extension Materials, Emphasizing Narrow Purpose of SealMay 5, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
